1. They can trickle out improvements one at a time, ensuring that there is always demand for a non-generic. 2. Perhaps you should look into how other countries

1. They can trickle out improvements one at a time, ensuring that there is always demand for a non-generic. 2. Perhaps you should look into how other countries regulate drug prices[1]. This is related to why residents of Florida recently pushed the FDA to allow them to buy drugs from Canada. There is a massive price difference, yet pharmaceutical companies somehow manage to make money off the Canadian market. I'd like to think the U.S. is subsidizing development costs for the rest of the world, as some big pharma executives have claimed in the past, but it's now evident that research would be easy to sustain at a lower price point. [1]https://www.canada.ca/en/patented-medicine-prices-review/services/regulatory-process.html https://www.canada.ca/en/patented-medicine-prices-review/ser...